Click here to get full coverage on BridgeBio heart drug lands late-breaking ACC slot with survival data - Stock Titan

BridgeBio heart drug lands late-breaking ACC slot with survival data  Stock Titan

BridgeBio heart drug lands late-breaking ACC slot with survival data - Stock Titan

Click here to get full coverage on Assessing BridgeBio Pharma (BBIO) Valuation After Recent Share Price Volatility - Yahoo Finance

Assessing BridgeBio Pharma (BBIO) Valuation After Recent Share Price Volatility  Yahoo Finance

Assessing BridgeBio Pharma (BBIO) Valuation After Recent Share Price Volatility - Yahoo Finance

Click here to get full coverage on Why This Top 10% Stock Surged On Pfizer's Patent Shake-Up - Investor's Business Daily

Why This Top 10% Stock Surged On Pfizer's Patent Shake-Up  Investor's Business Daily

Why This Top 10% Stock Surged On Pfizer's Patent Shake-Up - Investor's Business Daily

Click here to get full coverage on BBIO: Mizuho Raises Price Target to $106, Maintains 'Outperform' Rating | BBIO Stock News - GuruFocus

BBIO: Mizuho Raises Price Target to $106, Maintains 'Outperform' Rating | BBIO Stock News  GuruFocus

BBIO: Mizuho Raises Price Target to $106, Maintains 'Outperform' Rating | BBIO Stock News - GuruFocus

Click here to get full coverage on BridgeBio gives 29 new hires stock awards totaling 70,916 shares - Stock Titan

BridgeBio gives 29 new hires stock awards totaling 70,916 shares  Stock Titan

BridgeBio gives 29 new hires stock awards totaling 70,916 shares - Stock Titan

Click here to get full coverage on Is BridgeBio Pharma (BBIO) Attractive After Recent Pullback And Late Stage Pipeline Progress? - Yahoo Finance

Is BridgeBio Pharma (BBIO) Attractive After Recent Pullback And Late Stage Pipeline Progress?  Yahoo Finance

Is BridgeBio Pharma (BBIO) Attractive After Recent Pullback And Late Stage Pipeline Progress? - Yahoo Finance

Click here to get full coverage on BridgeBio Pharma (BBIO) President and CFO receives 59,041 RSU equity grant - Stock Titan

BridgeBio Pharma (BBIO) President and CFO receives 59,041 RSU equity grant  Stock Titan

BridgeBio Pharma (BBIO) President and CFO receives 59,041 RSU equity grant - Stock Titan

Click here to get full coverage on BridgeBio (BBIO) Soars 13% on Double-Digit Price Target Upgrade - Yahoo Finance

BridgeBio (BBIO) Soars 13% on Double-Digit Price Target Upgrade  Yahoo Finance

BridgeBio (BBIO) Soars 13% on Double-Digit Price Target Upgrade - Yahoo Finance

Click here to get full coverage on BridgeBio (BBIO) CAO awarded 14,170 RSUs in new equity grant - Stock Titan

BridgeBio (BBIO) CAO awarded 14,170 RSUs in new equity grant  Stock Titan

BridgeBio (BBIO) CAO awarded 14,170 RSUs in new equity grant - Stock Titan

Click here to get full coverage on A Look At BridgeBio Pharma (BBIO) Valuation After Strong Long Term Returns And Recent Share Pullback - Yahoo Finance

A Look At BridgeBio Pharma (BBIO) Valuation After Strong Long Term Returns And Recent Share Pullback  Yahoo Finance

A Look At BridgeBio Pharma (BBIO) Valuation After Strong Long Term Returns And Recent Share Pullback - Yahoo Finance

Click here to get full coverage on BridgeBio (BBIO) CEO Neil Kumar awarded options and 104,313 RSUs - Stock Titan

BridgeBio (BBIO) CEO Neil Kumar awarded options and 104,313 RSUs  Stock Titan

BridgeBio (BBIO) CEO Neil Kumar awarded options and 104,313 RSUs - Stock Titan

Click here to get full coverage on BridgeBio (BBIO) Tumbles 15%, Mirrors Marked Bleed - Yahoo Finance

BridgeBio (BBIO) Tumbles 15%, Mirrors Marked Bleed  Yahoo Finance

BridgeBio (BBIO) Tumbles 15%, Mirrors Marked Bleed - Yahoo Finance

Click here to get full coverage on BridgeBio Pharma (BBIO) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance

BridgeBio Pharma (BBIO) Reports Q4 Loss, Beats Revenue Estimates  Yahoo Finance

BridgeBio Pharma (BBIO) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance

Click here to get full coverage on How The BridgeBio Pharma (BBIO) Narrative Is Shifting With Attruby And Late Stage Pipeline - Yahoo Finance

How The BridgeBio Pharma (BBIO) Narrative Is Shifting With Attruby And Late Stage Pipeline  Yahoo Finance

How The BridgeBio Pharma (BBIO) Narrative Is Shifting With Attruby And Late Stage Pipeline - Yahoo Finance

Click here to get full coverage on Truist Raises Its Price Target on BridgeBio Pharma, Inc. (BBIO) to $95 and Maintains a Buy Rating - Yahoo Finance

Truist Raises Its Price Target on BridgeBio Pharma, Inc. (BBIO) to $95 and Maintains a Buy Rating  Yahoo Finance

Truist Raises Its Price Target on BridgeBio Pharma, Inc. (BBIO) to $95 and Maintains a Buy Rating - Yahoo Finance

Click here to get full coverage on Wells Fargo Remains a Buy on BridgeBio Pharma (BBIO) - Yahoo Finance

Wells Fargo Remains a Buy on BridgeBio Pharma (BBIO)  Yahoo Finance

Wells Fargo Remains a Buy on BridgeBio Pharma (BBIO) - Yahoo Finance

Click here to get full coverage on Analysts Remain Positive on BridgeBio Pharma, Inc. (BBIO) After Strong 2025 Results - Yahoo Finance

Analysts Remain Positive on BridgeBio Pharma, Inc. (BBIO) After Strong 2025 Results  Yahoo Finance

Analysts Remain Positive on BridgeBio Pharma, Inc. (BBIO) After Strong 2025 Results - Yahoo Finance

Click here to get full coverage on BridgeBio Pharma (BBIO) Achieves Record 2025 Revenue Driven by Attruby Commercial Success - Yahoo Finance

BridgeBio Pharma (BBIO) Achieves Record 2025 Revenue Driven by Attruby Commercial Success  Yahoo Finance

BridgeBio Pharma (BBIO) Achieves Record 2025 Revenue Driven by Attruby Commercial Success - Yahoo Finance

Click here to get full coverage on Assessing BridgeBio Pharma (BBIO) Valuation After Attruby Uptake And Pipeline Progress - Yahoo Finance

Assessing BridgeBio Pharma (BBIO) Valuation After Attruby Uptake And Pipeline Progress  Yahoo Finance

Assessing BridgeBio Pharma (BBIO) Valuation After Attruby Uptake And Pipeline Progress - Yahoo Finance

Click here to get full coverage on BridgeBio Pharma (BBIO) Valuation Check After Strong Phase 3 PROPEL 3 Results In Achondroplasia - Yahoo Finance

BridgeBio Pharma (BBIO) Valuation Check After Strong Phase 3 PROPEL 3 Results In Achondroplasia  Yahoo Finance

BridgeBio Pharma (BBIO) Valuation Check After Strong Phase 3 PROPEL 3 Results In Achondroplasia - Yahoo Finance

Click here to get full coverage on Why BridgeBio Pharma (BBIO) Is Up 10.6% After Breakthrough Phase 3 Infigratinib Data In Achondroplasia - Yahoo Finance

Why BridgeBio Pharma (BBIO) Is Up 10.6% After Breakthrough Phase 3 Infigratinib Data In Achondroplasia  Yahoo Finance

Why BridgeBio Pharma (BBIO) Is Up 10.6% After Breakthrough Phase 3 Infigratinib Data In Achondroplasia - Yahoo Finance

Click here to get full coverage on BridgeBio Pharma (BBIO) Surges 6.8%: Is This an Indication of Further Gains? - Yahoo Finance

BridgeBio Pharma (BBIO) Surges 6.8%: Is This an Indication of Further Gains?  Yahoo Finance

BridgeBio Pharma (BBIO) Surges 6.8%: Is This an Indication of Further Gains? - Yahoo Finance

Click here to get full coverage on Is BridgeBio Pharma (BBIO) Pricing Reflect Long Term Potential After 156.5% One Year Surge - Yahoo Finance

Is BridgeBio Pharma (BBIO) Pricing Reflect Long Term Potential After 156.5% One Year Surge  Yahoo Finance

Is BridgeBio Pharma (BBIO) Pricing Reflect Long Term Potential After 156.5% One Year Surge - Yahoo Finance

Click here to get full coverage on A Look At BridgeBio Pharma (BBIO) Valuation After Recent Share Price Volatility - simplywall.st

A Look At BridgeBio Pharma (BBIO) Valuation After Recent Share Price Volatility  simplywall.st

A Look At BridgeBio Pharma (BBIO) Valuation After Recent Share Price Volatility - simplywall.st

Click here to get full coverage on How Positive Phase 3 LGMD Data Could Shape BridgeBio Pharma’s (BBIO) Risk Profile and Upside Potential - simplywall.st

How Positive Phase 3 LGMD Data Could Shape BridgeBio Pharma’s (BBIO) Risk Profile and Upside Potential  simplywall.st

How Positive Phase 3 LGMD Data Could Shape BridgeBio Pharma’s (BBIO) Risk Profile and Upside Potential - simplywall.st

Click here to get full coverage on BridgeBio Pharma (BBIO): Exploring Valuation After a 20% Share Price Surge - Yahoo Finance

BridgeBio Pharma (BBIO): Exploring Valuation After a 20% Share Price Surge  Yahoo Finance

BridgeBio Pharma (BBIO): Exploring Valuation After a 20% Share Price Surge - Yahoo Finance

Click here to get full coverage on Mizuho Forecasts Strong Price Appreciation for BridgeBio Pharma (NASDAQ:BBIO) Stock - MarketBeat

Mizuho Forecasts Strong Price Appreciation for BridgeBio Pharma (NASDAQ:BBIO) Stock  MarketBeat

Mizuho Forecasts Strong Price Appreciation for BridgeBio Pharma (NASDAQ:BBIO) Stock - MarketBeat

Click here to get full coverage on BridgeBio muscular dystrophy trial hits key goals in Phase 3 study - Stock Titan

BridgeBio muscular dystrophy trial hits key goals in Phase 3 study  Stock Titan

BridgeBio muscular dystrophy trial hits key goals in Phase 3 study - Stock Titan

Click here to get full coverage on [144] BridgeBio Pharma, Inc. SEC Filing - Stock Titan

[144] BridgeBio Pharma, Inc. SEC Filing  Stock Titan

[144] BridgeBio Pharma, Inc. SEC Filing - Stock Titan

Click here to get full coverage on BridgeBio Pharma Inc (BBIO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Rising ... - Yahoo Finance

BridgeBio Pharma Inc (BBIO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Rising ...  Yahoo Finance

BridgeBio Pharma Inc (BBIO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Rising ... - Yahoo Finance

Click here to get full coverage on BridgeBio (BBIO) CEO’s family trusts sell 80,000 company shares - Stock Titan

BridgeBio (BBIO) CEO’s family trusts sell 80,000 company shares  Stock Titan

BridgeBio (BBIO) CEO’s family trusts sell 80,000 company shares - Stock Titan

Click here to get full coverage on BBIO (NASDAQ: BBIO) — Trustee and Insider 10b5-1 Sales Listed - Stock Titan

BBIO (NASDAQ: BBIO) — Trustee and Insider 10b5-1 Sales Listed  Stock Titan

BBIO (NASDAQ: BBIO) — Trustee and Insider 10b5-1 Sales Listed - Stock Titan

Click here to get full coverage on BBIO Stock Surges 17% Pre-Market Today – What’s Fueling The Rally? - Stocktwits

BBIO Stock Surges 17% Pre-Market Today – What’s Fueling The Rally?  Stocktwits

BBIO Stock Surges 17% Pre-Market Today – What’s Fueling The Rally? - Stocktwits

Click here to get full coverage on Biotech BridgeBio plans three March investor conference chats - Stock Titan

Biotech BridgeBio plans three March investor conference chats  Stock Titan

Biotech BridgeBio plans three March investor conference chats - Stock Titan

Click here to get full coverage on BridgeBio director sells 8,671 shares after option exercise | BBIO SEC Filing - Form 4 - Stock Titan

BridgeBio director sells 8,671 shares after option exercise | BBIO SEC Filing - Form 4  Stock Titan

BridgeBio director sells 8,671 shares after option exercise | BBIO SEC Filing - Form 4 - Stock Titan

Click here to get full coverage on LGMD trial drug lets people finish 100m test 31s faster than placebo - Stock Titan

LGMD trial drug lets people finish 100m test 31s faster than placebo  Stock Titan

LGMD trial drug lets people finish 100m test 31s faster than placebo - Stock Titan

Click here to get full coverage on BridgeBio (BBIO) director sells 25,484 shares after option exercise - Stock Titan

BridgeBio (BBIO) director sells 25,484 shares after option exercise  Stock Titan

BridgeBio (BBIO) director sells 25,484 shares after option exercise - Stock Titan

Click here to get full coverage on Three late-stage drug wins move BridgeBio toward six genetic treatments - Stock Titan

Three late-stage drug wins move BridgeBio toward six genetic treatments  Stock Titan

Three late-stage drug wins move BridgeBio toward six genetic treatments - Stock Titan

Click here to get full coverage on Has BridgeBio Pharma (BBIO) Run Too Far After 112% One Year Share Price Surge? - simplywall.st

Has BridgeBio Pharma (BBIO) Run Too Far After 112% One Year Share Price Surge?  simplywall.st

Has BridgeBio Pharma (BBIO) Run Too Far After 112% One Year Share Price Surge? - simplywall.st

Click here to get full coverage on 12 new BridgeBio hires receive stock grants vesting over time - Stock Titan

12 new BridgeBio hires receive stock grants vesting over time  Stock Titan

12 new BridgeBio hires receive stock grants vesting over time - Stock Titan

Click here to get full coverage on Boone Capital Management LLC Buys Shares of 460,282 BridgeBio Pharma, Inc. $BBIO - MarketBeat

Boone Capital Management LLC Buys Shares of 460,282 BridgeBio Pharma, Inc. $BBIO  MarketBeat

Boone Capital Management LLC Buys Shares of 460,282 BridgeBio Pharma, Inc. $BBIO - MarketBeat

Click here to get full coverage on Leerink Maintains Outperform on BBIO, BridgeBio Pharma, Inc. March 12, 2026 - Meyka

Leerink Maintains Outperform on BBIO, BridgeBio Pharma, Inc. March 12, 2026  Meyka

Leerink Maintains Outperform on BBIO, BridgeBio Pharma, Inc. March 12, 2026 - Meyka

Click here to get full coverage on Valantine plans option-based sale; prior 25,484 shares sold (BBIO) - Stock Titan

Valantine plans option-based sale; prior 25,484 shares sold (BBIO)  Stock Titan

Valantine plans option-based sale; prior 25,484 shares sold (BBIO) - Stock Titan

Click here to get full coverage on BridgeBio (BBIO) director trades 64,921 shares in 10b5-1 plan sale - Stock Titan

BridgeBio (BBIO) director trades 64,921 shares in 10b5-1 plan sale  Stock Titan

BridgeBio (BBIO) director trades 64,921 shares in 10b5-1 plan sale - Stock Titan

Click here to get full coverage on HighVista Strategies LLC Raises Holdings in BridgeBio Pharma, Inc. $BBIO - MarketBeat

HighVista Strategies LLC Raises Holdings in BridgeBio Pharma, Inc. $BBIO  MarketBeat

HighVista Strategies LLC Raises Holdings in BridgeBio Pharma, Inc. $BBIO - MarketBeat

Click here to get full coverage on BBIO Stock Surges 19% With A 5-day Spree On Positive Phase 3 Trial Data - Trefis

BBIO Stock Surges 19% With A 5-day Spree On Positive Phase 3 Trial Data  Trefis

BBIO Stock Surges 19% With A 5-day Spree On Positive Phase 3 Trial Data - Trefis

Click here to get full coverage on BridgeBio Pharma (BBIO) May Report Negative Earnings: Know the Trend Ahead of Q4 Release - Yahoo Finance

BridgeBio Pharma (BBIO) May Report Negative Earnings: Know the Trend Ahead of Q4 Release  Yahoo Finance

BridgeBio Pharma (BBIO) May Report Negative Earnings: Know the Trend Ahead of Q4 Release - Yahoo Finance

Click here to get full coverage on 34 new BridgeBio hires get 76,701 RSUs with vesting from 2027 - Stock Titan

34 new BridgeBio hires get 76,701 RSUs with vesting from 2027  Stock Titan

34 new BridgeBio hires get 76,701 RSUs with vesting from 2027 - Stock Titan

Click here to get full coverage on Cinctive Capital Management LP Sells 98,688 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat

Cinctive Capital Management LP Sells 98,688 Shares of BridgeBio Pharma, Inc. $BBIO  MarketBeat

Cinctive Capital Management LP Sells 98,688 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat

Click here to get full coverage on Granahan Investment Management LLC Buys 78,588 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat

Granahan Investment Management LLC Buys 78,588 Shares of BridgeBio Pharma, Inc. $BBIO  MarketBeat

Granahan Investment Management LLC Buys 78,588 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat

Click here to get full coverage on BridgeBio Pharma (BBIO) Valuation After Attruby-Driven Earnings Beat and Renewed Analyst Support - Yahoo Finance

BridgeBio Pharma (BBIO) Valuation After Attruby-Driven Earnings Beat and Renewed Analyst Support  Yahoo Finance

BridgeBio Pharma (BBIO) Valuation After Attruby-Driven Earnings Beat and Renewed Analyst Support - Yahoo Finance

Click here to get full coverage on (BBIO) Movement as an Input in Quant Signal Sets - Stock Traders Daily

(BBIO) Movement as an Input in Quant Signal Sets  Stock Traders Daily

(BBIO) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Click here to get full coverage on BridgeBio posts trial win for dwarfism drug (BBIO:NASDAQ) - Seeking Alpha

BridgeBio posts trial win for dwarfism drug (BBIO:NASDAQ)  Seeking Alpha

BridgeBio posts trial win for dwarfism drug (BBIO:NASDAQ) - Seeking Alpha

Click here to get full coverage on Prosight Management LP Sells 208,187 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat

Prosight Management LP Sells 208,187 Shares of BridgeBio Pharma, Inc. $BBIO  MarketBeat

Prosight Management LP Sells 208,187 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat

Click here to get full coverage on Intech Investment Management LLC Sells 19,826 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat

Intech Investment Management LLC Sells 19,826 Shares of BridgeBio Pharma, Inc. $BBIO  MarketBeat

Intech Investment Management LLC Sells 19,826 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat

Click here to get full coverage on Rafferty Asset Management LLC Sells 44,792 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat

Rafferty Asset Management LLC Sells 44,792 Shares of BridgeBio Pharma, Inc. $BBIO  MarketBeat

Rafferty Asset Management LLC Sells 44,792 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat

Click here to get full coverage on BridgeBio’s US$550 Million Notes Offering and ATTR-CM Push Could Be A Game Changer For BBIO - Yahoo Finance

BridgeBio’s US$550 Million Notes Offering and ATTR-CM Push Could Be A Game Changer For BBIO  Yahoo Finance

BridgeBio’s US$550 Million Notes Offering and ATTR-CM Push Could Be A Game Changer For BBIO - Yahoo Finance

Click here to get full coverage on BridgeBio Has More Room To Run (NASDAQ:BBIO) - Seeking Alpha

BridgeBio Has More Room To Run (NASDAQ:BBIO)  Seeking Alpha

BridgeBio Has More Room To Run (NASDAQ:BBIO) - Seeking Alpha

Click here to get full coverage on BridgeBio (BBIO) soars 13% on double-digit price target upgrade - MSN

BridgeBio (BBIO) soars 13% on double-digit price target upgrade  MSN

BridgeBio (BBIO) soars 13% on double-digit price target upgrade - MSN

Click here to get full coverage on BBIO: Strong late-stage pipeline and efficient commercial strategy drive growth outlook - TradingView

BBIO: Strong late-stage pipeline and efficient commercial strategy drive growth outlook  TradingView

BBIO: Strong late-stage pipeline and efficient commercial strategy drive growth outlook - TradingView

Click here to get full coverage on BridgeBio Pharma (BBIO) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance

BridgeBio Pharma (BBIO) Reports Q3 Loss, Beats Revenue Estimates  Yahoo Finance

BridgeBio Pharma (BBIO) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance

Click here to get full coverage on New Analyst Forecast: $BBIO Given $96 Price Target - Quiver Quantitative

New Analyst Forecast: $BBIO Given $96 Price Target  Quiver Quantitative

New Analyst Forecast: $BBIO Given $96 Price Target - Quiver Quantitative

Click here to get full coverage on BridgeBio Pharma Inc (BBIO) Q2 2025 Earnings Call Highlights: Record Revenue Surge and ... - Yahoo Finance

BridgeBio Pharma Inc (BBIO) Q2 2025 Earnings Call Highlights: Record Revenue Surge and ...  Yahoo Finance

BridgeBio Pharma Inc (BBIO) Q2 2025 Earnings Call Highlights: Record Revenue Surge and ... - Yahoo Finance

Click here to get full coverage on BBIO SEC Filings - Bridgebio Pharma 10-K, 10-Q, 8-K Forms - Stock Titan

BBIO SEC Filings - Bridgebio Pharma 10-K, 10-Q, 8-K Forms  Stock Titan

BBIO SEC Filings - Bridgebio Pharma 10-K, 10-Q, 8-K Forms - Stock Titan

Click here to get full coverage on (BBIO) Risk Channels and Responsive Allocation - Stock Traders Daily

(BBIO) Risk Channels and Responsive Allocation  Stock Traders Daily

(BBIO) Risk Channels and Responsive Allocation - Stock Traders Daily

Click here to get full coverage on BridgeBio Pharma CEO Kumar sells $6m in BBIO stock - Investing.com

BridgeBio Pharma CEO Kumar sells $6m in BBIO stock  Investing.com

BridgeBio Pharma CEO Kumar sells $6m in BBIO stock - Investing.com

Click here to get full coverage on JP Morgan Raises Price Target for BridgeBio Pharma (BBIO) to $94 - GuruFocus

JP Morgan Raises Price Target for BridgeBio Pharma (BBIO) to $94  GuruFocus

BBIO

Price Chart

Key Statistics

Technicals

About BBIO

Latest News

BridgeBio heart drug lands late-breaking ACC slot with survival data - Stock Titan

Assessing BridgeBio Pharma (BBIO) Valuation After Recent Share Price Volatility - Yahoo Finance

Why This Top 10% Stock Surged On Pfizer's Patent Shake-Up - Investor's Business Daily

Advanced Charts

Top Gainers

Top Losers